Abstract
Curcumin ((1E,6E)-1,7-bis(4-hydroxy-3-methoxyphenyl) hepta-1,6-diene-3,5-dione) is a naturally occurring polyphenol. We have investigated effects of curcumin on human erythrocytes membrane naïve and subjected to in vitro oxidative stress by incubating with tert-butylhydroperoxide (t-BHP). Human erythrocytes have been chosen for the study model due to their being the primary target site for the oxidative stress generated by extracellular as well as intracellular metabolic pathway and substances. Acetylcholinesterase (AChE) in the erythrocytes membrane shows many properties similar to those of brain tissues AChE activity may be considered as central cholinergic status. Results show that curcumin (10-5 M to 10-8 M) significantly (p<0.001) protects AChE activity in erythrocyte during oxidative stress. AChE activity in naïve membrane was found to be maximum at 10-6 M of curcumin. Curcumin at 10-6 M caused decrease in Km of the enzyme Our results signify the potential protective effect of curcumin on the cholinergic system under conditions of oxidative stress.
Keywords: Acetylcholine esterase, Antioxidants, Curcumin, Malondialdehyde, Oxidative stress, Membrane fluidity.
Letters in Drug Design & Discovery
Title:Curcumin Activates Erythrocyte Membrane Acetylcholinesterase
Volume: 10 Issue: 6
Author(s): Prabhakar Singh and Syed Ibrahim Rizvi
Affiliation:
Keywords: Acetylcholine esterase, Antioxidants, Curcumin, Malondialdehyde, Oxidative stress, Membrane fluidity.
Abstract: Curcumin ((1E,6E)-1,7-bis(4-hydroxy-3-methoxyphenyl) hepta-1,6-diene-3,5-dione) is a naturally occurring polyphenol. We have investigated effects of curcumin on human erythrocytes membrane naïve and subjected to in vitro oxidative stress by incubating with tert-butylhydroperoxide (t-BHP). Human erythrocytes have been chosen for the study model due to their being the primary target site for the oxidative stress generated by extracellular as well as intracellular metabolic pathway and substances. Acetylcholinesterase (AChE) in the erythrocytes membrane shows many properties similar to those of brain tissues AChE activity may be considered as central cholinergic status. Results show that curcumin (10-5 M to 10-8 M) significantly (p<0.001) protects AChE activity in erythrocyte during oxidative stress. AChE activity in naïve membrane was found to be maximum at 10-6 M of curcumin. Curcumin at 10-6 M caused decrease in Km of the enzyme Our results signify the potential protective effect of curcumin on the cholinergic system under conditions of oxidative stress.
Export Options
About this article
Cite this article as:
Singh Prabhakar and Rizvi Syed Ibrahim, Curcumin Activates Erythrocyte Membrane Acetylcholinesterase, Letters in Drug Design & Discovery 2013; 10 (6) . https://dx.doi.org/10.2174/1570180811310060012
DOI https://dx.doi.org/10.2174/1570180811310060012 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Changes in Bone Turnover, Bone Mineral and Fracture Risk Induced by Drugs Used to Treat Epilepsy
Current Drug Safety Alzheimer’s Disease, Astrocytes and Kynurenines
Current Alzheimer Research The Role of Blood-Brain Barrier Transporters in Pathophysiology and Pharmacotherapy of Stroke
Current Pharmaceutical Design Lower Frequency of co-Morbid Medical Disorders Related to Poor Impulse Control in Parkinson’s than Alzheimer’s Disease
Current Aging Science The Safety of Medications for the Treatment of Bipolar Disorder During Pregnancy and the Puerperium
Current Drug Safety Recent Progress in Syntheses and Biological Activities of Kainic Acid and its Derivatives
Current Organic Chemistry Gene Therapy for Brain Cancer: Combination Therapies Provide Enhanced Efficacy and Safety
Current Gene Therapy Melatonin and Respiratory Diseases: A Review
Current Topics in Medicinal Chemistry Management of Antiepileptic Treatment After Epilepsy Surgery - Practices and Problems
Current Pharmaceutical Design The Role of the Urokinase Receptor in Epilepsy, in Disorders of Language, Cognition, Communication and Behavior, and in the Central Nervous System
Current Pharmaceutical Design Outcome of Newborns with Neonatal Seizures: Risk Factors and Predictors
Current Pediatric Reviews Conference Report: Summary Report of the International Association of Neurorestoratology VII Conference: Regulations, Ethics, Science, and the Need of Patients Care in Neurorestoratology
CNS & Neurological Disorders - Drug Targets Preface:
Recent Patents and Topics on Imaging (Discontinued) Pharmacology and Drug Discovery for T-Type Calcium Channels
CNS & Neurological Disorders - Drug Targets Understanding Abnormal c-JNK/p38MAPK Signaling in Amyotrophic Lateral Sclerosis: Potential Drug Targets and Influences on Neurological Disorders
CNS & Neurological Disorders - Drug Targets Central Nervous System Manifestations in Systemic Lupus Erythematosus
Current Rheumatology Reviews Mitochondrial Complex I Deficiency in Humans
Current Genomics Editorial [Hot Topic: New Mechanisms of Neuronal Injury and Neuroprotection (Guest Editor: Weihai Ying)]
Current Drug Targets Editorial [Hot Topic: When Can a Drug be Declared “Safe”? (Guest Editors: Frank M.C. Besag & Seetal Dodd)]
Current Drug Safety SkQ-1 Regulates Xanthine Oxidase Activity in the Settings of Epilepsic Seizures in Rats
Neuroscience and Biomedical Engineering (Discontinued)